December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand D1

2023 Edition

Cherry Biotech

fr

Cherry Biotech, a biomedical tech (Organ on Chip) firm, develops instruments for drug discovery and personalized medicine. We aim to replace animal testing by cultivating human tissue (Organoids) in vitro for drug evaluation.
CubiX platform recreates immunocompetent human vascularized organ models and tumor microenvironments. This platform can uniquely transform a 2D multi-well plate into a 3D cell culture (Organ on Well), creating human 3D models mirroring physiology and pathophysiology.

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.